[go: up one dir, main page]

Kusagawa et al., 1999 - Google Patents

HIV type 1 env subtype E in Cambodia

Kusagawa et al., 1999

Document ID
8890095633038470747
Author
Kusagawa S
Sato H
Kato K
Nohtomi K
Shiino T
Samrith C
Leng H
Phalla T
Heng M
Takebe Y
Publication year
Publication venue
AIDS research and human retroviruses

External Links

Snippet

SINCE THE FIRST human immunodeficiency virus type 1 (HIV-1) infection was detected in a blood donor in the Cambodian capital of Phnom Penh in 1991, HIV-1 has spread rapidly in this Southeast Asian country. 1 Rates among blood donors rose from 0.08% in 1991 to 4.5 …
Continue reading at www.liebertpub.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus

Similar Documents

Publication Publication Date Title
Rodenburg et al. Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents
McCUTCHAN et al. Genetic variants of HIV-1 in Thailand
Holmes et al. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient.
Rushlow et al. Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus
AU601397B2 (en) Retrovirus of the hiv-2 type susceptible of inducing aids, and its antigenic and nucleic constituents
Motomura et al. Emergence of new forms of human immunodeficiency virus type 1 intersubtype recombinants in central Myanmar
Liitsola et al. An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination
JP2020515234A5 (en)
Tebit et al. Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon
GASMI et al. Long terminal repeat sequence analysis of HTLV type I molecular variants identified in four north African patients
Kusagawa et al. HIV type 1 env subtype E in Cambodia
ENGELBRECHT et al. Identification of env subtypes in fourteen HIV type 1 isolates from South Africa
Vandamme et al. Evolutionary strategies of human T-cell lymphotropic virus type II
Alcantara et al. Brazilian HTLV type 2a strains from intravenous drug users (IDUs) appear to have originated from two sources: Brazilian Amerindians and European/North American IDUs
BROWN et al. Sequence Note: HIV Type 1 Subtypes in Malaysia Include B, C, and E
Yanagihara et al. Molecular phylogeny and dissemination of human T-cell lymphotropic virus type 1 viewed within the context of primate evolution and human migration
Gessain et al. Phylogenetic study of ten new HTLV-I strains from the Americas
Tuppin et al. Evidence in Gabon for an intrafamilial clustering with mother‐to‐child and sexual transmission of a new molecular variant of human T‐lymphotropic virus type‐II subtype B
Kato et al. Differential prevalence of HIV type 1 subtype B and CRF01_AE among different sexual transmission groups in Tokyo, Japan, as revealed by subtype-specific PCR
Azran et al. Implications of the evolution pattern of human T-cell leukemia retroviruses on their pathogenic virulence
Kim et al. Characterization of V3 loop sequences from HIV type 1 subtype B in South Korea: predominance of the GPGS motif
Dominguez et al. Envelope sequence variation and phylogenetic relations of human T cell lymphotropic virus type 1 from endemic areas of Colombia
ELLERBROK et al. Sequence analysis of two HTLV type I infections imported to Germany
EP1309617B1 (en) Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof
Munkanta et al. Predominance of three NF-κB binding sites in the long terminal repeat region of HIV type 1 subtype C isolates from Zambia